Overview

Efficacy and Safety of THR-4109 in Obese Subjects

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effect of THR-4109 on weight loss in obese subjects over a 24-week treatment period.
Phase:
Phase 2
Details
Lead Sponsor:
Theracos
Collaborator:
TFS Trial Form Support